COVID-19 vaccine race: watch your step for cancer patientsCOVID-19 백신 경쟁: 암 환자의 발걸음을 조심하십시오Comment Published on 2020-12-072022-08-31 Journal: British Journal of Cancer [Category] MERS, SARS, 치료제, [키워드] accumulate Administered appraisal benefit Cancer Cancer immunotherapy cancer patient carriers COVID-19 vaccination COVID-19 vaccine dose Dosing Efficacy expected Health policy lipid carrier Liposome mRNA mRNA COVID-19 vaccine mRNA COVID-19 vaccines mRNAs Patient permeation solid tumour the vaccine tissue Tumours vaccine candidate vaccine dose [DOI] 10.1038/s41416-020-01219-3 PMC 바로가기 [Article Type] Comment
Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)고형암 환자의 코로나19(COVID-19) 중증도 및 사망률과 이 질병이 항암 치료에 미치는 영향에 대한 위험 요인: 프랑스 전국 코호트 연구(GCO-002 CACOVID-19)Article Published on 2020-12-012022-09-11 Journal: European journal of cancer (Oxford, England : 1990 [Category] SARS, 치료기술, 치료법, 치료제, [키워드] 95%CI acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Administered Admission age all-cause mortality analysed Analysis anticancer Cancer cancer patient Cancer patients cancers Care Chain Reaction characteristics of patients Charlson Comorbidity Index Chemotherapy cohort study collected data Comorbidity Cooperative coronavirus coronavirus disease Coronavirus disease 2019 Corticosteroid Corticosteroids COVID-19 COVID-19 diagnosis COVID-19 severity Cytotoxic chemotherapy death defined deleterious effect detectable diagnosed diagnosis of COVID-19 digestive except for Factor Factors French group ICU immune Immunotherapy increased risk independent Infection intensive care intensive care unit investigated Male sex Mechanical mechanical ventilation Mortality Multivariate analysis Odds ratio Patient patients patients died performance polymerase chain polymerase chain reaction Predictive primary end-point Radiotherapy respiratory reverse transcriptase Reverse transcriptase polymerase chain reaction risk of death RT-PCR SARS-CoV-2 scale severity slight increase solid cancer patient solid tumour subgroup of patient subgroup of patients the disease therapy Thoracic thought transcriptase Treatment Tumours with COVID-19 [DOI] 10.1016/j.ejca.2020.09.035 PMC 바로가기 [Article Type] Article
BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: A structured summary of a study protocol for a randomised controlled trialCOVID-19에 대한 타고난 면역 반응을 개선하기 위해 브라질에서 의료 종사자의 BCG 재접종: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약Letter Published on 2020-10-262022-08-13 Journal: Trials [Category] MERS, SARS, 임상, [키워드] accompany activate acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus-2 Admission Antibiotics antiviral immune response approved assigned Autoimmune Autoimmune diseases Bacillus BCG BCG revaccination BCG vaccination bcg vaccine blinded Blinding block blocks both groups Brazil Breastfeeding carried CFU Characteristics Chemotherapy childhood city clinical trial Committee Comorbidities Comorbidity confirmation Contact contact with control group Coronavirus-2 COVID-19 COVID-19 patient COVID-19 severity COVID-19 symptoms COVID-19 test cross-protection determined by diagnosed direct contact disease disease severity Diseases dissemination dose doses Effectiveness element elicited eligibility criteria Fever health worker health workers healthcare providers HIV hospital Hypothesis ICU identification number IgG and IgM IgM and IgG IgM test immunosuppressive IMPROVE in both group incidence incidence of COVID-19 Inclusion inclusion criteria India induce Infection infections information innate immune response investigator Laboratory lateral flow less macrophages medication meet memory monocyte Monocytes Mortality naso-oropharyngeal swab neutrophil Neutrophils NK NK cell number Nurses objective Open-label outcome outcomes pandemic parallel-group participant physiotherapists platform presenting Prevent Primary outcome Primary outcomes professional protocol randomisation randomised randomised controlled trial randomization Randomized receive recruit recruitment reduce Registered registration number researcher researchers respiratory revaccination right arm RT-PCR Sample size SARS-CoV-2 scar sealed Secondary objective Secondary objectives secondary outcome severe acute respiratory syndrome Coronavirus severity solid tumour specimen statistical analyses status steroid Study protocol Symptom symptomatic infection the disease the vaccine Trial Trial registration Tuberculosis two groups vaccination Vaccine virus virus infection virus infections was performed website WHO [DOI] 10.1186/s13063-020-04822-0 PMC 바로가기 [Article Type] Letter
Low Incidence of SARS-CoV-2 in Patients with Solid Tumours on Active Treatment: An Observational Study at a Tertiary Cancer Centre in Lombardy, ItalyArticle Published on 2020-08-202022-10-31 Journal: Cancers [Category] COVID-19, [키워드] analysed appear Cancer cancer care cancer centre cancer patient Cancer patients Care Chemotherapy China Clinical characteristics Combination continuum correlation COVID-19 Fatality rate General population hospitalisation Immunotherapy In-hospital incidence Infection intravenous Italy lombardy material median median age metastatic disease outcome pandemic Patient Prognosis Registered reported required resulting retrospective data risk factor SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2-positive patient SARS-CoV-2-positive patients Solid solid tumour targeted therapy Tertiary therapy treated Treatment treatment safety [DOI] 10.3390/cancers12092352 PMC 바로가기 [Article Type] Article
Treatment of cancer patients during the COVID-19 pandemic in the PhilippinesShort Communication Published on 2020-05-082022-10-31 Journal: ecancermedicalscience [Category] COVID-19, [키워드] Cancer cancer patient Cancer patients Care caused COVID-19 pandemic Isolation management oncologist Patient Philippines recommendation Safe solid tumour treatment guideline [DOI] 10.3332/ecancer.2020.1040 PMC 바로가기 [Article Type] Short Communication